News

MarketWatch27d
ImmunityBio Slides Following FDA Refusal-to-File Letter
Shares of ImmunityBio touched a 52-week low after the company received a refusal-to-file letter from the Food and Drug Administration for a supplemental biologics license application for bladder ...
Benzinga.com27d
ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug
Save your free seat now. ImmunityBio, Inc. IBRX on Monday received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for the supplemental biologics license ...
Yahoo Finance27d
ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency’s Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary ...
May 05, 2025--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that the Company received a Refusal to File (RTF) letter from the U.S. Food and ...
Forbes3mon
Service Staffers Resign After DOGE Takeover—Citing Refusal To ‘Dismantle Critical Public Services’
At least 21 former staffers of the U.S. Digital Service resigned Tuesday, citing the agency’s takeover by Elon Musk’s Department of Government Efficiency and a refusal to “dismantle critical ...
NBC News3mon
21 U.S. DOGE Service staffers resign over a refusal to 'jeopardize Americans' sensitive data,' letter says
Twenty-one civil service employees resigned en masse from Elon Musk's Department of Government Efficiency, according to a letter posted online and shared with media outlets on Tuesday. The letter ...